Engenomics
Enzynomics is a South Korean biotechnology company that develops and supplies approximately 200 high-purity recombinant enzymes and experimental kits for molecular biology research, serving academic institutions, pharmaceutical/biotech firms, and IVD manufacturers across 8+ countries.
- Company typePrivate
- Founded2007
- HeadquartersDaejeon, South Korea
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Engenomics does
Enzynomics Co., Ltd. is a privately held South Korean biotechnology company founded in 2007 and headquartered in Daejeon that develops and supplies recombinant enzymes and experimental kits for molecular biology research and in vitro diagnostics. Its catalog comprises approximately 200 high-purity recombinant enzymes produced in E. coli expression systems, including 130+ restriction enzymes, 20+ DNA polymerases, 50+ modifying enzymes, and 60+ cytokines spanning human, mouse, rat, and canine species, alongside bundled kits for PCR, qPCR, reverse transcription, cloning, NGS library preparation, mutagenesis, and in vitro transcription.
The company's technology is anchored in proprietary enzyme variants branded under EZ-CleanCut™ (star-activity-free restriction enzymes), TOPscript™ (high-temperature reverse transcriptase active at 60°C), RbTaq™ (Repebody-based hot-start PCR polymerase), TOPreal™ (qPCR reagent systems), and EZ-Fusion™ (homology-based seamless cloning), with all custom production conducted under ISO 13485:2016 quality standards suitable for diagnostic applications. Production is centered at the company's Daejeon headquarters in the Daejeon Science and Technology Complex, with an earlier sales office in Seoul.
Enzynomics monetizes primarily through one-time sales of individual enzymes and pre-configured kits via its own e-commerce storefront (enzynomics.com), a regional Korean distributor network covering all major provinces, and direct export to 8+ countries including Germany and the United States. The company also offers a custom enzyme development service under ISO 13485 standards. Primary customer segments are academic research institutions and universities (horizontal long-tail), pharmaceutical and biotechnology companies developing mRNA vaccines, gene therapies, and antisense therapeutics (vertical), and IVD/diagnostics manufacturers requiring ISO-grade bulk enzyme supply. The company is currently pursuing a KOSDAQ listing on the Korea Exchange following an initial rejection in June 2024.
Engenomics firmographics
Firmographics- Name
- Engenomics
- Legal name
- Enzynomics Co., Ltd.
- Website
- https://enzynomics.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Enzynomics is a South Korean biotechnology company that develops and supplies approximately 200 high-purity recombinant enzymes and experimental kits for molecular biology research, serving academic institutions, pharmaceutical/biotech firms, and IVD manufacturers across 8+ countries.
- Ownership category
- akta.pro rank
Engenomics industry classification
Industry- Product category
- Life Sciences Research Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Engenomics is headquartered
LocationHeadquarters
- HQ city
- Daejeon
- HQ country
- South Korea
- HQ region
- Asia
Offices2 records
Markets served
Engenomics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Enzyme Product Sales: Direct sales of molecular biology enzymes including restriction enzymes, polymerases, reverse transcriptases, and modifying enzymes through the company's e-commerce platform and distributor network.
- Experiment Kits Sales: Sales of pre-configured experimental kits including cloning kits, mutagenesis kits, PCR kits, NGS library preparation kits, and RNA synthesis kits.
- Cytokine Product Sales: Sales of high-purity recombinant cytokines for research applications, produced in E. coli expression systems.
- Customized Service: Custom enzyme development and production services tailored to specific customer requirements, produced under ISO 13485:2016 quality standards.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Cytokine products - priced by mass (10μg to 1mg) |
| Unit Pricing | Pay-as-you-go | Human EGF - 100μg to 1mg sizes |
| Unit Pricing | Pay-as-you-go | Restriction enzymes - priced by activity units |
| Unit Pricing | Pay-as-you-go | Human RNase H1 - 100μg size |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Engenomics product offering
Product offeringCore offering
Enzynomics develops, manufactures, and supplies approximately 200 high-purity recombinant enzymes (restriction enzymes, DNA/RNA polymerases, reverse transcriptases, modifying enzymes), 60 recombinant cytokines, and a range of experimental kits (cloning, mutagenesis, NGS library prep, nucleic acid purification, RNA synthesis, qPCR, reporter assays) for molecular biology research and diagnostic applications. All enzymes are produced in E. coli expression systems under ISO 9001, ISO 14001, and ISO 13485 certifications, with sales via the company's e-commerce site, Korean regional distributors, and direct export.
Product overview
Enzynomics is a research enzyme company offering a comprehensive portfolio of approximately 200 high-purity recombinant enzymes and related kits for molecular biology research. The product portfolio includes: (1) Restriction Enzymes - over 130 types including standard enzymes and EZ-CleanCut™ variants designed to eliminate star activity; (2) PCR & Real-time PCR Products - encompassing nTaq, RbTaq™ (using proprietary Repebody technology), nPfu-Forte high-fidelity polymerase, and TOPreal™ qPCR kits using SYBR Green or probe-based detection; (3) Reverse Transcriptases - including M-MLV, TOPscript™ (improved variant enabling cDNA synthesis at 60°C), and SuperiorScript variants; (4) DNA/RNA Polymerases - including Phi29, Bst, T7/T3/SP6 RNA polymerases; (5) Cloning & Mutagenesis Kits - including TOPcloner™ (topoisomerase-based TA/blunt cloning), EZ-Fusion™ HT (Gibson-like seamless assembly), EZchange™ (site-directed), and EZ™ Random Mutagenesis kits; (6) Next Generation Sequencing Products - including EZ-Seq™ RNA/DNA library prep kits, EZ-Tera™ XT kit, and various library prep modules; (7) Nucleic Acid Purification - including EZ-Pure™ plasmid, PCR purification, gel extraction, and RNA prep kits; (8) RNA Synthesis - including EZ™ High Yield In Vitro Transcription kits and mRNA synthesis solutions with capping enzymes; (9) Modifying Enzymes - over 50 types including ligases, kinases, nucleases (including Cas9), proteases, and RNase inhibitors; (10) Cytokines - over 60 types of recombinant human, mouse, rat, and canine cytokines including interleukins, interferons, growth factors, and neurotrophic factors; (11) Electrophoresis & Detection Products - including TOPview™ protein ladders, ECL substrates, DNA markers, and EZ-SolSafe™ staining solution; (12) Premade Buffers and Nucleotides; (13) Nano Block Delivery System - cell delivery reagents developed with partner company NS Biotechnology. The company also offers custom enzyme development services under ISO 13485:2016 standards.
Differentiator
Problem solved
Functional benefit
Brands
- EZ-CleanCut™: Restriction enzyme product line designed to address star activity issues
- TOPsimple™
- TOPscript™
- TOPreal™
- EZ-Fusion™
- TOPcloner™
- EZchange™
- RbTaq™
- EZ-Seq™
- EZ™
- TOPview™
- NANO BLOCK
Products and services
- Restriction Enzymes (EZ-CleanCut™ and standard portfolio) High-purity recombinant restriction enzymes including 130+ standard endonucleases and the proprietary EZ-CleanCut™ line engineered to eliminate star activity, supplied with heat-inactivation capability and EzBuffer I–IV compatibility for recombinant DNA experiments and gene analysis.
- PCR Polymerases (nTaq, nTaq-HOT, nTaq-Tenuto, nPfu-Forte, RbTaq™, EZ™ Plant Direct PCR) Comprehensive range of PCR polymerases for standard, hot-start, high-fidelity, plant-direct, and Repebody-based hot-start PCR amplification, including nPfu-Forte which retains over 95% activity after 60 minutes at 95°C.
- DNA/RNA Polymerases (Phi29, Bst, T7, SP6, E. coli Poly(A), Sulfolobus DNA Pol IV) Specialty polymerases for rolling circle amplification, isothermal amplification, in vitro transcription from T7/SP6/T3 promoters, mRNA poly(A) tailing, and translesion DNA synthesis.
- Reverse Transcriptases (M-MLV, TOPscript™, SuperiorScript) Reverse transcriptases for cDNA synthesis from RNA templates, including the proprietary TOPscript™ that synthesizes cDNA at 60°C for complex RNA templates with secondary structures, and TOPscript™ RT-PCR kits for one-step workflows.
- Real-time PCR Kits (TOPreal™ SYBR Green and Probe PreMIX) Real-time PCR reagent mixes in SYBR Green and TaqMan probe chemistries with High-ROX, UDG, and combined variants for instrument compatibility, plus one-step RT-qPCR kits for direct RNA quantification.
- Cloning & Mutagenesis Kits (TOPcloner™, EZ-Fusion™, EZchange™, EZ™ Random Mutagenesis) Kits for TA cloning, blunt-end cloning, long-fragment cloning, homology-based seamless assembly (EZ-Fusion™ HT supporting up to 4 fragments), site-directed mutagenesis (EZchange™), random mutagenesis, and multiplex DNA fragment assembly into restriction-enzyme-linearized vectors.
- NGS Library Preparation Kits (EZ-Seq™ RNA/DNA, EZ-Tera™ XT, modules) Library preparation solutions for next-generation sequencing including RNA library prep kits, low-input DNA library kits, Tn5-based tagmentation kits, end-repair/dA-tailing/adaptor ligation modules, and magnetic bead-based size selection (EZ-Pure™ SPRI Beads).
- Nucleic Acid Purification Kits (EZ-Pure™ Plasmid, PCR, Gel, RNA, Genomic DNA, ExoAP) Kits for plasmid DNA preparation, PCR product purification, gel extraction, total RNA miniprep, genomic DNA prep, and enzymatic PCR cleanup for downstream molecular biology applications.
- RNA Synthesis & mRNA Production Kits (EZ™ High Yield IVT, T7 mRNA Synthesis, Poly(A) Tailing, Vaccinia Capping, 2'-O-Methyltransferase) High-yield in vitro transcription kits using T7/T3/SP6 polymerases, T7 mRNA synthesis kits (including modified nucleotide support), Poly(A) tailing kits, and capping enzymes (Vaccinia Capping Enzyme and mRNA Cap 2'-O-Methyltransferase) for producing capped, stable mRNA for research and therapeutic applications.
- Reporter Assay Kits (EZ™ Luciferase Assay System) Firefly luciferase-based reporter assay kit for mammalian, plant, and bacterial cells with enhanced sensitivity and stability using coenzyme A.
- Modifying Enzymes (T4/T7 DNA Ligases, T4 RNA Ligases, T4 PNK, Inorganic Pyrophosphatase, Benzonase, Lambda Exonuclease, Exonuclease III, RNase H, Human RNase H1, RNase R, Cas9, RNase Inhibitor, UDG, TEV Protease, Tn5 Transposase, NTP/dNTP Production Enzymes) Broad set of modifying enzymes for DNA/RNA manipulation including DNA and RNA ligases, kinases, exonucleases, RNases, CRISPR Cas9 nuclease, RNase inhibitors, uracil-DNA glycosylase, TEV protease, Tn5 transposase, and nucleotide kinases for in-house NTP/dNTP production.
- Electrophoresis & Detection Products (TOPview™ Protein Ladder, TOPview™ ECL Western Substrate, DNA Ladders, EZ™ Agarose Tablets, EZ-SolSafe™ Staining Solution) Protein and DNA molecular weight markers, ECL chemiluminescence substrates for Western blot detection, pre-weighed agarose tablets, and a safe protein gel staining solution that detects proteins in 30 minutes without harmful chemicals.
- Nucleotides (dNTP Mixtures, rNTP Set, Oligo dT and Random Hexamer) Deoxynucleotide and ribonucleotide solutions for PCR, in vitro transcription, and reverse transcription, plus Oligo dT and random hexamer primers for cDNA synthesis.
- Premade Buffers (PBS, Tris-HCl, TE, TAE, TBE, SSC, others) High-quality ready-to-use laboratory buffers produced without enzyme activity inhibition for consistent experimental results.
- Recombinant Cytokines (Human, Mouse, Rat, Canine) Approximately 60 high-purity recombinant cytokines including interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17, IL-20, IL-21, IL-22, IL-33, IL-36α), interferons (IFN-γ), TNF-α, growth factors (EGF, FGF family, VEGF), neurotrophic factors (BDNF, GDNF), and species-specific counterparts for mouse, rat, and canine research models.
- Nano Block Delivery System (Protein, Antibody, Nucleic Acid Delivery Kits) Cellular delivery system for introducing proteins, antibodies, and nucleic acids into mammalian cells for research applications, developed and produced by partner NS Biotechnology and distributed by Enzynomics.
- Customized Enzyme Development Service Custom enzyme development and production service covering over 200 different enzyme types, executed under ISO 13485:2016 quality standards to meet bespoke customer requirements for molecular biology and diagnostic applications.
Quantifiable outcome
- Enzymes demonstrate >95-98% purity by SDS-PAGE analysis
- +2 more outcomes
Companies that use Engenomics
Customer profileSegments3 records
Ideal customer profiles3 records
Engenomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Engenomics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NS Bio Technologies (엔이에스 바이오테크놀러지)coreNS Bio Technologies developed and produces the Nano Block Delivery System, which Enzynomics distributes as part of its product portfolio. This partnership enables Enzynomics to offer cell delivery solutions for bioactive molecules including proteins, antibodies, and nucleic acids.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Engenomics competitors and assessment
Company assessmentDirect peers
- New England Biolabs: The global leader in restriction enzymes and molecular biology enzyme reagents with a 200+ restriction enzyme catalog and broad polymerase/RT portfolio. Directly comparable product set to Enzynomics' core business and the primary global competitor.
- Takara Bio: Japanese molecular biology tools company with strong presence in restriction enzymes, polymerases, cloning kits, and cell biology reagents. Highly comparable product set to Enzynomics, especially across Asian academic and biotech markets.
- Jena Bioscience: German molecular biology reagents company offering restriction enzymes, polymerases, nucleotides, and cloning reagents. Direct product competitor in Germany — one of Enzynomics' key export markets.
- Promega: US-based research reagents and molecular biology tools company with broad enzyme, RT, PCR, and cloning portfolios. Direct product overlap with Enzynomics' core enzyme business across academic and pharma research customers.
- Bioneer: Korean molecular biology tools company offering restriction enzymes, polymerases, oligos, and molecular diagnostics. Closest geographic and product peer to Enzynomics — both target Korean research market with similar product breadth and size profile.
- Toyobo: Japanese specialty chemicals and life sciences company producing research enzymes including polymerases and diagnostic enzymes. Comparable enzyme manufacturing capabilities and Asian market presence, with similar focus on E. coli-expressed research-grade proteins.
- Qiagen: Global molecular biology sample preparation and assay reagents provider with broad PCR, RT, and cloning reagent portfolio. Comparable in workflow reagents for molecular biology applications, especially in sample prep and IVD-adjacent segments.
Broad incumbents
- Merck KGaA (MilliporeSigma): Global life sciences tools giant offering restriction enzymes, polymerases, and molecular biology reagents through Sigma-Aldrich and MilliporeSigma brands. Broad incumbent with deep relationships at major academic and pharma accounts globally.
- Thermo Fisher Scientific: Global life sciences tools giant offering molecular biology enzymes and kits through the Invitrogen brand. Operates broadly across research, IVD, and pharma channels — overlapping with Enzynomics' product portfolio but at vastly larger scale and brand recognition.
Emerging players
- ACROBiosystems: US/Asian-headquartered recombinant protein and cytokine supplier with a catalog breadth comparable to Enzynomics' cytokine business. Directly competes in the research cytokine segment with broader species coverage and growing global distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Engenomics social profiles
Digital presenceEngenomics compliance and trust
Trust signalCompliance3 records
Engenomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Engenomics leadership team
Management profileNumber of profiles
Profiles3 records
Engenomics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Engenomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Engenomics
What does Engenomics do?
Enzynomics develops, manufactures, and supplies approximately 200 high-purity recombinant enzymes (restriction enzymes, DNA/RNA polymerases, reverse transcriptases, modifying enzymes), 60 recombinant cytokines, and a range of experimental kits (cloning, mutagenesis, NGS library prep, nucleic acid purification, RNA synthesis, qPCR, reporter assays) for molecular biology research and diagnostic applications. All enzymes are produced in E. coli expression systems under ISO 9001, ISO 14001, and ISO 13485 certifications, with sales via the company's e-commerce site, Korean regional distributors, and direct export.
Is Engenomics a public or private company?
Engenomics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Engenomics founded?
Engenomics was founded in 2007. It employs 1 to 10 people.
Where is Engenomics based?
Engenomics is headquartered in Daejeon, South Korea, in the Asia region.
How does Engenomics make money?
Four revenue lines are on record. Enzyme Product Sales are the primary driver. The others are experiment Kits Sales, cytokine Product Sales and customized Service.
Who are Engenomics's main competitors?
Direct peers on record are New England Biolabs, Takara Bio, Jena Bioscience, Promega, Bioneer, Toyobo and Qiagen. Broad incumbents are Merck KGaA (MilliporeSigma) and Thermo Fisher Scientific. ACROBiosystems is listed as an emerging player.
Does Engenomics have an API?
No public API is recorded for Engenomics.
What industry is Engenomics in?
Engenomics's product category is Life Sciences Research Reagents. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 325413 and its SIC code is 2835.